| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.21 | 5e-09 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-06 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.16 | 9e-06 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0003 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |